Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX

Lexicon Pharmaceuticals (LXRX) Technical Analysis

1,318 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Lexicon Pharmaceuticals’s (LXRX) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Lexicon Pharmaceuticals is a Sell.
Lexicon Pharmaceuticals’s (LXRX) 20-Day exponential moving average is 1.99, while Lexicon Pharmaceuticals’s (LXRX) share price is $2.39, making it a Buy.
Lexicon Pharmaceuticals’s (LXRX) 50-Day exponential moving average is 1.89, while Lexicon Pharmaceuticals’s (LXRX) share price is $2.39, making it a Buy.

Lexicon Pharmaceuticals (LXRX) Pivot Points

Jul 27, 2024, 02:02 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.87
2.00
2.08
2.21
2.29
2.42
2.50
Fibonacci
2.00
2.08
2.13
2.21
2.29
2.34
2.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lexicon Pharmaceuticals (LXRX) Moving Averages

Jul 27, 2024, 02:02 AM
Period
Simple
Exponential
MA5
2.16Buy
2.20Buy
MA10
2.14Buy
2.11Buy
MA20
1.90Buy
1.99Buy
MA50
1.82Buy
1.89Buy
MA100
1.92Buy
1.87Buy
MA200
1.74Buy
1.73Buy
Lexicon Pharmaceuticals’s (LXRX) 10-Day exponential moving average is 2.11, while Lexicon Pharmaceuticals’s (LXRX) share price is $2.39, making it a Buy.
Lexicon Pharmaceuticals’s (LXRX) 100-Day exponential moving average is 1.87, while Lexicon Pharmaceuticals’s (LXRX) share price is $2.39, making it a Buy.
Lexicon Pharmaceuticals’s (LXRX) stock price is $2.39 and Lexicon Pharmaceuticals’s (LXRX) 50-day simple moving average is 1.82, creating a Buy signal.
Lexicon Pharmaceuticals’s (LXRX) stock price is $2.39 and Lexicon Pharmaceuticals’s (LXRX) 100-day simple moving average is 1.92, creating a Buy signal.
Lexicon Pharmaceuticals’s (LXRX) stock price is $2.39 and Lexicon Pharmaceuticals’s (LXRX) 200-day simple moving average is 1.74, creating a Buy signal.

Lexicon Pharmaceuticals (LXRX) Technical Indicators

Jul 27, 2024, 02:02 AM
Name
Value
Implied Action
RSI (14)
67.41
Neutral
STOCH (9,6)
76.19
Neutral
STOCHRSI (14)
84.19
Sell
MACD (12,26)
0.13
Sell
ADX (14)
40.82
Neutral
Williams %R
-13.48
Sell
CCI (14)
118.65
Sell
ATR (14)
0.16
-
Ultimate Oscillator
52.79
Neutral
ROC
39.52
Buy
Lexicon Pharmaceuticals’s (LXRX) Relative Strength Index (RSI) is 67.41, creating a Neutral signal.
Lexicon Pharmaceuticals’s (LXRX) Trend Strength Indicator (ADX) is 40.82, creating a Neutral signal.
Lexicon Pharmaceuticals’s (LXRX) Commodity Channel Index (CCI) is 118.65, creating a Sell signal.
Lexicon Pharmaceuticals’s (LXRX) Price Rate of Change (ROC) is 39.52, creating a Buy signal.

FAQ

Is LXRX a Buy, Hold, or Sell?
Based on LXRX’s technical indicators, LXRX is a Buy.
    What is LXRX’s RSI (14)?
    LXRX’s RSI (14) is 67.41, which suggests LXRX is a Neutral.
      What is LXRX’s MACD?
      LXRX’s MACD is 0.13, which suggests LXRX is a Sell.
        What is LXRX’s 5-day moving average?
        LXRX’s 5-day moving average is 2.16, which suggests LXRX is a Buy.
          What is LXRX’s 20-day moving average?
          LXRX 20-day moving average is 1.90, which suggests LXRX is a Buy.
            What is LXRX’s 50-day moving average?
            LXRX’s 50-day moving average is 1.82, which suggests LXRX is a Buy.
              What is LXRX’s 200-day moving average?
              LXRX’s 200-day moving average is 1.74, which suggests LXRX is a Buy.
                What is LXRX’s Williams % R (14)?
                LXRX’s Williams % R (14) is -13.48, which suggests LXRX is a Sell.
                  What is LXRX’s CCI (14)?
                  LXRX’s CCI (14) is 118.65, which suggests LXRX is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis